Research Site — Oak Lawn, Illinois

Research Site is a clinical research site located in Oak Lawn, Illinois, United States 60068.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 14 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus Infections, Ulcerative Colitis, IBD.

Sponsors: MedImmune LLC, AstraZeneca, Padagis LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Lawn

Browse all research sites in Illinois · View every site in Oak Lawn

• Advocate Christ Hospital and Medical Center
• Advocate Christ Medical Center-Hospital
• Advocate Chilldren's Hospital
• Adcovate Christ Hospital
• Advocate Hope Children's Hospital
• Advocate Childrens Hospital
• Advocate Children's Hospital
• Advocate Health and Hospital
• Advocate Christ Hospital
• Advocate Christ Hospital & Medical Center
• Christ Hospital
• Hope Children's Hospital

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 14 clinical trials on record. Their work covers Respiratory Syncytial Virus Infections, Ulcerative Colitis, IBD.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.